Study Group: Rheumatoid Arthritis Specialists (EU)(?)
Council Members in this Study Group: 13
This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.
Request a survey with this Study Group
Related Study Groups
| Study Group Name | Members |
|---|---|
| Rheumatologists (EU) | 209 |
| Rheumatologists | 860 |
| Gouty Arthritis Specialists (EU) | 28 |
| Rituxan Prescribers: Rheumatologists | 35 |
| Niaspan Prescribers for Raising HDL | 143 |
| Sports Medicine Physicians | 159 |
GLG NewsSMAnalyses by this Study Group's Leading Experts(?)
Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
Analysis of:
Trubion Announces Initiation of Phase 1 Study of SBI-087 for the Treatment of Rheumatoid Arthritis | www.pipelinereview.com
- the next generation of SMIP technology beyond antibody therapy enters clinical trials - the value of efficacy versus safety as compared to TRU-015 and the anti-CD20 antiobodies will be of key importance if it makes sense to broaden this spectrum of second generation anti-CD20s - however, it gives...
Most Common Company Types:
- Academic Medical Center/Hospital or Clinic
- Government/Military Hospital or Clinic
- Academic Institution*
- Office Based Private Practice or Clinic
Most Common Job Types:
- Physician - Attending Physician
- Physician - Division Head
- Lecturer
GLG's 850+ Clients Include:
Fortune 500®
companies
40 of the leading 50
global mutual funds
15 of the leading 20
global banks
8 of the leading 10
global private equity firms
5 of the top 10
AmLaw firms